We've found
25,125
archived clinical trials in
Diabetes
We've found
25,125
archived clinical trials in
Diabetes
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials

Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials

Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials

Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
Updated: 3/22/2016
An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/22/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Status: Enrolling
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Updated: 3/24/2016
Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials

Study of Topical Ocular PAN-90806 in PDR
Updated: 3/24/2016
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Study of Topical Ocular PAN-90806 in PDR
Updated: 3/24/2016
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials

Study of Topical Ocular PAN-90806 in PDR
Updated: 3/24/2016
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Study of Topical Ocular PAN-90806 in PDR
Updated: 3/24/2016
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Updated: 3/25/2016
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: An Open-Label, Randomized, 52-week Study
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials

Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials

Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
Updated: 3/29/2016
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes Treatment
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials

Mechanisms of Glycemic Improvement After Gastrointestinal Surgery
Updated: 3/29/2016
Mechanisms of Glycemic Improvement After Gastrointestinal Surgery
Status: Enrolling
Updated: 3/29/2016
Mechanisms of Glycemic Improvement After Gastrointestinal Surgery
Updated: 3/29/2016
Mechanisms of Glycemic Improvement After Gastrointestinal Surgery
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials

Home-Based Interventions for Adolescents With Type 1 Diabetes
Updated: 3/29/2016
Translating Home-Based Interventions for Adolescents With Poorly Controlled TID
Status: Enrolling
Updated: 3/29/2016
Home-Based Interventions for Adolescents With Type 1 Diabetes
Updated: 3/29/2016
Translating Home-Based Interventions for Adolescents With Poorly Controlled TID
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Status: Enrolling
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Updated: 3/29/2016
The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation
Status: Enrolling
Updated: 3/29/2016
Click here to add this to my saved trials

Exposure to Type II Diabetes for Two Siblings With the Same Parents
Updated: 4/1/2016
Metabolic Traits of Adult Sib-pairs Discordant for Intrauterine Diabetes Exposure.
Status: Enrolling
Updated: 4/1/2016
Exposure to Type II Diabetes for Two Siblings With the Same Parents
Updated: 4/1/2016
Metabolic Traits of Adult Sib-pairs Discordant for Intrauterine Diabetes Exposure.
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Updated: 4/4/2016
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated: 4/4/2016
Click here to add this to my saved trials

Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
Updated: 4/5/2016
Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
Status: Enrolling
Updated: 4/5/2016
Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
Updated: 4/5/2016
Brief Alcohol Intervention to Reduce At-Risk Drinking Among Type 2 Diabetics
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials

[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Updated: 4/6/2016
Exploration of the Use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection.
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Updated: 4/6/2016
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Status: Enrolling
Updated: 4/6/2016
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Updated: 4/6/2016
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
Updated: 4/6/2016
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
Status: Enrolling
Updated: 4/6/2016
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
Updated: 4/6/2016
Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

Diet and Exercise Intervention in Type 2 Diabetes
Updated: 4/6/2016
Diet and Exercise Intervention in Type 2 Diabetes
Status: Enrolling
Updated: 4/6/2016
Diet and Exercise Intervention in Type 2 Diabetes
Updated: 4/6/2016
Diet and Exercise Intervention in Type 2 Diabetes
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Updated: 4/7/2016
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated: 4/7/2016
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Updated: 4/7/2016
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Updated: 4/7/2016
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated: 4/7/2016
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Updated: 4/7/2016
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated: 4/7/2016
Click here to add this to my saved trials
